Latest News about GSK
Recent news which mentions GSK
FDA Fuels Respiratory Syncytial Virus Vaccine Race While Backing GSK's Candidate Soon After Pfizer's
March 02, 2023
From Benzinga
3 Crucial Things to Know About Moderna Right Now
February 27, 2023
From Motley Fool
GSK's Relief For Few Months, First Trial Claiming Zantac Caused Cancer Pushed Into Late 2023
February 24, 2023
Tickers
GSK
From Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Healthcare Stocks Delivering High-Dividend Yields
February 23, 2023
From Benzinga
GSK/Pfizer-Backed ViiV Healthcare's HIV Treatment At Par With Gilead's: Study Shows
February 23, 2023
From Benzinga
Intel and 9 Other Companies With Dividend Cuts in 2023
February 22, 2023
From InvestorPlace
My 3 Biggest Stock Market Predictions for March
February 21, 2023
From Motley Fool
This chart gives one reason European stocks may continue to outperform U.S. equities
February 17, 2023
From MarketWatch
EXCLUSIVE: How To Lower The Cost Of Cannabis Quality And Save 30% Of Your Top-Line Revenue
February 15, 2023
From Benzinga
JNJ Terminates NASH Program Pact With Arrowhead Pharmaceuticals
February 15, 2023
From Benzinga
Vir Biotech To Work On Next-Gen COVID-19 Solutions Independently, Or With Other Partners, As GSK Walks Out
February 14, 2023
From Benzinga
FDA AdComm Votes In Favor Of GSK's Jemperli Single Arm Trial Plan For Rectal Cancer Setting
February 10, 2023
Tickers
GSK
From Benzinga
FDA Grants Complete Approval For GSK's Jemperli For Endometrial Cancer
February 10, 2023
Tickers
GSK
From Benzinga
Earnings Scheduled For February 1, 2023
February 01, 2023
From Benzinga
GSK posts higher sales and profit of $1.85 billion, lifted by specialty medicines and vaccines businesses
February 01, 2023
Tickers
GSK
From MarketWatch
From Benzinga
CureVac Shares Pop After Encouraging Update From COVID-19, Flu mRNA Vaccine Programs
January 30, 2023
From Benzinga
3 Penny Stocks That Could Make You Filthy Rich
January 25, 2023
From Motley Fool
From Benzinga
From Motley Fool
From Benzinga
Moderna Gets A 'Booster' Shot: Why Stock Is Up Nearly 7% Today
January 18, 2023
From Benzinga
Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government’s pandemic response
January 09, 2023
From MarketWatch
From InvestorPlace
GSK Looking For Under-Appreciated M&A Targets, Not Trying To Be Next Roche Or AstraZeneca
December 30, 2022
From Benzinga
7 Drug Stocks That Will Soar in 2023
December 22, 2022
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
